Omnicell and Fresenius Kabi Join Forces to Improve Controlled Substance Management
Omnicell
JANUARY 10, 2023
Through a new collaboration between Omnicell and Fresenius Kabi, a global healthcare company focusing on infusion, transfusion, and clinical nutrition, health systems now have new options to manage controlled substances better, reduce diversion, and save nursing time.
40 
Let's personalize your content